293 related articles for article (PubMed ID: 11978897)
1. Translational medicine: targetting cyclo-oxygenase isozymes to prevent cancer.
Sharma RA
QJM; 2002 May; 95(5):267-73. PubMed ID: 11978897
[No Abstract] [Full Text] [Related]
2. Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs.
Patrono C; Patrignani P; García Rodríguez LA
J Clin Invest; 2001 Jul; 108(1):7-13. PubMed ID: 11435450
[No Abstract] [Full Text] [Related]
3. The new NSAIDs: cox-2 inhibitors.
Capriotti T
Medsurg Nurs; 2000 Dec; 9(6):313-7. PubMed ID: 11904867
[No Abstract] [Full Text] [Related]
4. COX-2 inhibitors: cancer prevention or cardiovascular risk?
Senior K
Lancet Oncol; 2005 Feb; 6(2):68. PubMed ID: 15704289
[No Abstract] [Full Text] [Related]
5. [Clinical pharmacology of selective inhibitors of cyclooxygenase-2].
Patrignani P
Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):13-8, 37-40. PubMed ID: 15058604
[No Abstract] [Full Text] [Related]
6. [Thinking about the specific cyclooxygenase-2 inhibitors since its recommendation].
Shi G
Zhonghua Nei Ke Za Zhi; 2001 Sep; 40(9):579-80. PubMed ID: 11758234
[No Abstract] [Full Text] [Related]
7. [Topical pharmacology. COX-2 inhibitors].
Heinzl S
Med Monatsschr Pharm; 1999 Oct; 22(10):298-304. PubMed ID: 10540801
[No Abstract] [Full Text] [Related]
8. Cyclo-oxygenase 2 inhibitors: an important new drug classification.
Kessenich CR
Pain Manag Nurs; 2001 Mar; 2(1):13-8. PubMed ID: 11705156
[TBL] [Abstract][Full Text] [Related]
9. Selective cyclo-oxygenase-2 inhibitors and myocardial infarction: how strong is the link?
Howes LG; Krum H
Drug Saf; 2002; 25(12):829-35. PubMed ID: 12241124
[TBL] [Abstract][Full Text] [Related]
10. The coxibs, selective inhibitors of cyclooxygenase-2.
FitzGerald GA; Patrono C
N Engl J Med; 2001 Aug; 345(6):433-42. PubMed ID: 11496855
[No Abstract] [Full Text] [Related]
11. [Therapeutic advances with coxibs: few certainties and a lot of doubts].
Jouzeau JY; Daouphars M; Netter P
Therapie; 2004; 59(2):207-11. PubMed ID: 15359614
[No Abstract] [Full Text] [Related]
12. [Specific inhibitors of cyclooxygenase-2 (COX-2): current knowledge and perspectives].
Rioda WT; Nervetti A
Acta Biomed Ateneo Parmense; 2001; 72(3-4):55-64. PubMed ID: 11889908
[TBL] [Abstract][Full Text] [Related]
13. The new COX-2 inhibitors: rofecoxib (Vioxx) and celecoxib (Celebrex).
Wynn RL
Gen Dent; 2000; 48(1):16-20. PubMed ID: 11199547
[No Abstract] [Full Text] [Related]
14. Regulation of cyclo-oxygenase-2.
Stack E; DuBois RN
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):787-800. PubMed ID: 11566041
[TBL] [Abstract][Full Text] [Related]
15. [Rapid, strong and long-term effectiveness. Coxib also effective in toothache].
MMW Fortschr Med; 2003 Jan; 145(1-2):53. PubMed ID: 12638443
[No Abstract] [Full Text] [Related]
16. [New anti-inflammatory analgetics--are they needed?].
Paakkari I
Duodecim; 1999; 115(20):2217-24. PubMed ID: 11973925
[No Abstract] [Full Text] [Related]
17. [Therapy with preferential and specific COX-2 inhibitors].
Stichtenoth DO; Frölich JC
Internist (Berl); 2001 Mar; 42(3):421-6. PubMed ID: 11277028
[No Abstract] [Full Text] [Related]
18. Effect of cyclooxygenase-2 inhibitors on blood pressure.
Johnson DL; Hisel TM; Phillips BB
Ann Pharmacother; 2003 Mar; 37(3):442-6. PubMed ID: 12639178
[TBL] [Abstract][Full Text] [Related]
19. An update on specific COX-2 inhibitors: the COXIBs.
Gupta S; Crofford LJ
Bull Rheum Dis; 2001; 50(1):1-4. PubMed ID: 12092091
[No Abstract] [Full Text] [Related]
20. COX-2 inhibitors in oncology.
Haller DG
Semin Oncol; 2003 Aug; 30(4 Suppl 12):2-8. PubMed ID: 14508721
[No Abstract] [Full Text] [Related]
[Next] [New Search]
